under construction
  • Twitter
  • YouTube
  • Instagram

For People with Advanced MS

CHARIOTMS is a groundbreaking  clinical trial.

It will test whether Cladribine Tablets (MAVENCLAD©), an established treatment for highly active relapsing MS, can preserve upper limb function in Advanced MS, where people have largely lost the ability to walk.

These are the 44% of people with MS who currently have very limited  treatment options.

CHARIOTMS is the first disease modifying treatment trial for wheechair users .

CHARIOTMS is the first trial with no upper age limit.

 

videoicon4.png
Prof Klaus Schmierer,
Chief Investigator, ChariotMS
THE TRIAL
Trial Information
and Sites

THE  SCIENCE

wheelchairanddumbell.png

Advanced MS

mavenclad.jpg

Cladribine
image?

Screenshot 2021-02-14 at 12.23.34.png

COMMMUNITY

The Team

blog.jpg

COVID UPDATES for MS